Your home for biotech and planetary health insight and opinion.
Let's build rapport.
Raven-built Aliada shuttles its potential best-in-class Alzheimer’s treatment to Abbvie
As we congratulate the Aliada team on its deal with AbbVie, we wanted to share a bit more of the story behind the second significant acquisition from our Raven incubator this year and the first full-circle acquisition of a company we built with technology spun out from a larger company.
*By providing your email, you are opting in to receiving marketing communications from RA Capital Management and its affiliates. We will never share your email.